Expression of kinin receptor mRNA in the HPA axis of type 1 and type 2 diabetic rats

International Immunopharmacology

Volumn 4, Issue 4, 2004, Pages 571-576

  Qadri, Fatimunnisa ^a   Stark, Eva ^a   Häuser, Walter ^a   Jöhren, Olaf ^a   Dendorfer, Andreas ^a   Dominiak, Peter ^a  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

Author keywords

HPA axis; Kinin receptors; Obese Zucker rats; STZ induced diabetes; ZDF rats

Indexed keywords

GLUCOSE; KININ B1 RECEPTOR; KININ B2 RECEPTOR; MESSENGER RNA; NEUROTRANSMITTER; RECEPTOR; STREPTOZOCIN; UNCLASSIFIED DRUG;

ADRENAL GLAND; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIABETIC OBESITY; GENE EXPRESSION; GLUCOSE BLOOD LEVEL; HYPOPHYSIS ADRENAL SYSTEM; HYPOTHALAMUS; HYPOTHALAMUS HYPOPHYSIS SYSTEM; INSULIN DEPENDENT DIABETES MELLITUS; MALE; NEUROTRANSMITTER RELEASE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; RAT; STREPTOZOCIN DIABETES;

ANIMALS; BLOOD GLUCOSE; BODY WEIGHT; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; INSULIN; LEPTIN; MALE; PITUITARY-ADRENAL SYSTEM; RATS; RATS, SPRAGUE-DAWLEY; RATS, ZUCKER; RECEPTOR, BRADYKININ B1; RECEPTOR, BRADYKININ B2; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 16544364807     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.intimp.2004.02.005     Document Type: Article

References (23)

1. Regoli D., Barabe J. Pharmacology of bradykinin and related kinins. Pharmacol. Rev. 32:1980;1-46.
2. Couture R., Lindsey C.J. Brain Kallikrein-kinin system: from receptor to neuronal pathways and physiological functions. Quirion R., Böjorklund A., Hökfelt T. Peptide Receptors, Part I. Handbook of Chemical Neuroanatomy. vol. 16:2000;241-300 Elsevier, Amsterdam.
3. Kaplan A.P., Joseph K., Silverberg M. Pathways for bradykinin formation and inflammatory disease. J. Allergy Clin. Immunol. 109:2002;195-209.
4. Zuccollo A., Navarro M., Frontera M., Cueva F., Carattino M., Catanzaro O.L. The involvement of kallikrein-kinin system in diabetes type I (insulitis). Immunopharmacology. 45:1999;69-74.
5. Cloutier F., Couture R. Pharmacological characterization of the cardiovascular responses elicited by kinin B(1) and B(2) receptor agonists in the spinal cord of streptozotocin-diabetic rats. Br. J. Pharmacol. 130:2000;375-385.
6. de Sousa Buck H., Ongali B., Thibault G., Lindsey C.J., Couture R. Autoradiographic detection of kinin receptors in the human medulla of control, hypertensive, and diabetic donors. Can. J. Physiol. Pharmacol. 80:2002;249-257.
7. Junod A., Lambert A.E., Orci L., Pictet R., Gonet A.E., Renold A.E. Studies of the diabetogenic action of streptozotocin. Proc. Soc. Exp. Biol. Med. 126:1967;201-205.
8. Peterson R.G., Shaw W.N., Neel M.-A., Littli L.A., Eichberg J. Zucker diabetic fatty rats as a model for non-insulin-dependent diabetes mellitus. ILAR J. Online. 32(3):1990.
9. Kava R., Greenwood M.R.C., Johnson P.R. Zucker (fa/fa) rat. ILAR J. Online. 32(3):1990.
10. Chan O., Chan S., Inouye K., Vranic M., Matthews S.G. Molecular regulation of the hypothalamo-pituitary-adrenal axis in streptozotocin-induced diabetes: effects of insulin treatment. Endocrinology. 142:2001;4872-4879.
11. Guillaume-Gentil C., Rohner-Jeanrenaud F., Abramo F., Bestetti G.E., Rossi G.L., Jeanrenaud B. Abnormal regulation of the hypothalamo-pituitary- adrenal axis in the genetically obese fa/fa rat. Endocrinology. 126:1990;1873-1879.
12. Qadri F., Arens T., Schwartz E.-C., Häuser W., Dendorfer A., Klein H.-H.et al. Altered brain nitric oxide synthase activity in spontaneously hypertensive rats. J. Hypertens. 21:2003;1387-1696.
13. Qadri F., Häuser W., Jöhren O., Dominiak P. Kinin B1 and B2 receptor mRNA expression in the hypothalamus of spontaneously hypertensive rats. Can. J. Physiol. Pharmacol. 80:2002;258-263.
14. Mage M., Pecher C., Neau E., Cellier E., Dos Reiss M.L., Schanstra J.P.et al. Induction of B1 receptors in streptozotocin diabetic rats: possible involvement in the control of hyperglycemia-induced glomerular Erk 1 and 2 phosphorylation. Can. J. Physiol. Pharmacol. 80:2002;328-333.
15. Pheng L.H., Nguyen-Le X.K., Nsa Allogho S., Gobeil F., Regoli D. Kinin receptors in the diabetic mouse. Can. J. Physiol. Pharmacol. 75:1997;609-611.
16. Cloutier F., de Sousa Buck H., Ongali B., Couture R. Pharmacologic and autoradiographic evidence for an up-regulation of kinin B(2) receptors in the spinal cord of spontaneously hypertensive rats. Br. J. Pharmacol. 135:2002;1641-1654.
17. Tschöpe C., Heringer-Walther S., Koch M., Spillmann F., Wendorf M., Hauke D.et al. Myocardial bradykinin B2-receptor expression at different time points after induction of myocardial infarction. J. Hypertens. 18:2000;223-228.
18. 2 receptor localization and expression in the hypothalamo-pituitary-adrenal axis of spontaneously hypertensive rats. Int. Immunopharmacology. 3:2003;285-292.
19. Madeddu P., Anania V., Alagna S., Troffa C., Parpaglia P.P., Tonolo G.et al. Role of brain kallikrein-kinin system in regulation of adrenocorticotropin release. Am. J. Physiol. 262:1992;E312-E318.
20. Kim E.M., O'Hare E., Grace M.K., Welch C.C., Billington C.J., Levine A.S. ARC POMC mRNA and PVN alpha-MSH are lower in obese relative to lean zucker rats. Brain Res. 862:2000;11-16.
21. Dendorfer A., Dominiak P. Characterization of bradykinin receptors mediating catecholamine release in PC12 cells. Naunyn-Schmiedeberg's Arch. Pharmacol. 351:1995;274-281.
22. 2 receptor localization and expression in the hypothalamo-pituitary-adrenal axis of spontaneously hypertensive rats. Int. Immunopharmacology. 3:2003;285-292.
23. Morrison J.F., Howarth F.C., Sheen R. Catecholamines in the heart and adrenal gland of the STZ-diabetic rat. Arch. Physiol. Biochem. 109:2001;206-208.